[HTML][HTML] Comparison of MRI-based response criteria and radiomics for the prediction of early response to transarterial radioembolization in patients with hepatocellular …
G Aujay, C Etchegaray, JF Blanc, B Lapuyade… - Diagnostic and …, 2022 - Elsevier
Purpose The purpose of this study was to evaluate the capabilities of radiomics using
magnetic resonance imaging (MRI) data in the assessment of treatment response to 90 …
magnetic resonance imaging (MRI) data in the assessment of treatment response to 90 …
Interventional liver-directed therapy for neuroendocrine metastases: current status and future directions
Opinion statement Liver-directed therapy should be considered for patients with
unresectable liver metastases from neuroendocrine tumor if symptomatic or progressing …
unresectable liver metastases from neuroendocrine tumor if symptomatic or progressing …
[HTML][HTML] Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy
AAKA Razek, LG El-Serougy, GA Saleh… - Diagnostic and …, 2020 - Elsevier
Purpose To determine inter-reader agreement in categorizing hepatocellular carcinoma
(HCC) treated with locoregional therapy using the Liver Imaging Reporting and Data System …
(HCC) treated with locoregional therapy using the Liver Imaging Reporting and Data System …
[HTML][HTML] Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria
M Ghosn, H Derbel, R Kharrat, N Oubaya… - Diagnostic and …, 2021 - Elsevier
Purpose To evaluate the potential of imaging criteria in predicting overall survival of patients
with hepatocellular carcinoma (HCC) after a first transcatheter arterial yttrium-90 …
with hepatocellular carcinoma (HCC) after a first transcatheter arterial yttrium-90 …
Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory
W Badar, T Van Ha, S Zangan… - The British Journal of …, 2021 - academic.oup.com
Objective: To study the efficacy and safety of repeat transarterial radioembolization (TARE)
to similar hepatic arterial territories. Methods: Between 3/2011 and 4/2019, 26 patients (25 …
to similar hepatic arterial territories. Methods: Between 3/2011 and 4/2019, 26 patients (25 …
Inflammatory scores: correlation with clinical outcomes in hepatocellular carcinoma patients undergoing transarterial radioembolization
Purpose To evaluate the ability of neutrophil-to-lymphocyte ratio (NLR), platelet-to-
lymphocyte ratio (PLR), aspartate aminotransferase-to-lymphocyte ratio (ALRI) and systemic …
lymphocyte ratio (PLR), aspartate aminotransferase-to-lymphocyte ratio (ALRI) and systemic …
[90Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to “TheraSphere” for Cost-Effective Treatment of Liver Cancer
KV Vimalnath, A Rajeswari, A Dixit… - Cancer Biotherapy & …, 2024 - liebertpub.com
Background: Selective internal radiation therapy (SIRT) using a suitable β−-emitting
radionuclide is a promising treatment modality for unresectable liver carcinoma. Yttrium-90 …
radionuclide is a promising treatment modality for unresectable liver carcinoma. Yttrium-90 …